据国家统计局数据，截至2025年末，全国生猪存栏42,967万头，比上年末增加224万头，同比增长 0.5%。报告期内，面对竞争日益激烈的市场环境，公司管理层与全体员工团结一心、锐意进取、攻坚 克难，持续加大研发力度，加快新产品研发进展，不断提升市场竞争力，带动收入和利润稳步增长。 格隆汇2月27日丨科前生物(688526.SH)公布2025年度业绩快报，2025年公司实现营业收入9.50亿元，较 上年增加0.89%；实现归属于母公司所有者的净利润4.16亿元，较上年增加8.70%。 ...

格隆汇2月27日丨科前生物(688526.SH)公布2025年度业绩快报，2025年公司实现营业收入9.50亿元，较 上年增加0.89%；实现归属于母公司所有者的净利润4.16亿元，较上年增加8.70%。 据国家统计局数据，截至2025年末，全国生猪存栏42,967万头，比上年末增加224万头，同比增长 0.5%。报告期内，面对竞争日益激烈的市场环境，公司管理层与全体员工团结一心、锐意进取、攻坚 克难，持续加大研发力度，加快新产品研发进展，不断提升市场竞争力，带动收入和利润稳步增长。 ...

证券代码：688526 证券简称：科前生物 公告编号：2026-002 武汉科前生物股份有限公司 2025年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担法律责任。 本公告所载武汉科前生物股份有限公司（以下简称"公司"） 2025年度主要财务数据为初步核算数据，未经会计师事务所审计， 具体数据以公司2025年年度报告中披露的数据为准，提请投资者 注意投资风险。 一、2025年度主要财务数据和指标 单位：人民币元 1 | 总资产 | 4,790,335,880.58 | 4,495,821,916.06 | 6.55 | | --- | --- | --- | --- | | 归属于上市公司股 东的所有者权益 | 4,242,116,569.09 | 3,940,969,701.00 | 7.64 | | 股本（股） | 466,128,056.00 | 466,128,056.00 | 0.00 | | 归属于上市公司股 东的每股净资产 | 9.14 | 8.49 | 7.66 | | （元） | | | | 注：1、 ...

国泰海通发布研报称，2026年1月，淘天宠物与炼丹炉大数据联合发布《宠物行业新品趋势报告》显 示，时令节日仪式感消费已成为"它经济"的核心增长极，"新年宠物礼盒"这一搜索关键词在天猫平台上 的同比增速便已经达到了20%+。根据天猫数据，宠物过年衣服销量实现330%的大幅增长，宠物年夜饭 实现290%的增长。此外，春节后，华南与华北区域举办规模领先的宠物展会，国内头部品牌预计在展 会上推出新品，值得关注。 养殖：春节后预期猪价进入淡季节奏 春节后预期猪价进入淡季节奏。春节后预计需求淡而供给多，预期价格进入淡季节奏。事实上腊月小年 后，春节备货已经开始逐步下降，接下来节后的屠宰场正月初七和初八正式开工后，价格将进入低价和 养殖亏损阶段。关注低猪价下的产能去化情况。 标的方面 生猪推荐标的：牧原股份(002714.SZ)、温氏股份(300498.SZ)；后周期推荐标的：科前生物 (688526.SH)、海大集团(002311.SZ)。农产品产业链推荐标的：晨光生物(300138.SZ)、诺普信 (002215.SZ)、荃银高科（维权）(300087.SZ)、国投丰乐(000713.SZ)，相关标的：康农种业 (30 ...

Investment Rating - The report maintains an "Overweight" rating for the pet economy sector, highlighting its rapid growth during the Spring Festival [4][7]. Core Insights - The pet consumption during the Spring Festival has seen significant growth, with a 20%+ year-on-year increase in searches for "New Year pet gift boxes" on Tmall. The sales of pet clothing surged by 330%, and pet New Year's dinners increased by 290% [7]. - The report emphasizes the comprehensive nature of pet services, with a 46% month-on-month increase in pet boarding demand. The expansion of pet transport services on high-speed trains and airlines is also noted [7]. - Upcoming pet exhibitions in March are expected to further stimulate market interest, with major brands likely to launch new products [7]. Summary by Sections Important Industry Data Overview - The agricultural sector index stands at 2,858.1, with a year-on-year increase of 14.28%. The wholesale price index for agricultural products is at 129.6, reflecting a 4.95% year-on-year increase [10]. - The average price of live pigs is 12.3 yuan/kg, down 15.81% year-on-year, while the average price of piglets is 471.0 yuan/head, down 25.24% year-on-year [10]. Pig Farming Sector - The report anticipates a seasonal decline in pig prices post-Spring Festival, with expectations of low prices leading to potential losses in farming [5][12]. - Recommended stocks in the pig farming sector include Muyuan Foods and Wens Foodstuffs, with additional recommendations in the agricultural product supply chain [5]. Poultry Sector - The report discusses the white feather broiler market, noting a decrease in chick prices and stable prices for broiler meat [19][20]. - The average price of broiler chicks is reported at 2.4 yuan/chick, with a 4.35% increase month-on-month [10]. Feed Sector - The report indicates stable feed prices, with corn prices at 2,372.2 yuan/ton and soybean meal prices at 3,167.7 yuan/ton [10][30]. - The analysis highlights the fluctuations in import prices for soybeans and corn, impacting the feed sector [32]. Key Company Profit Forecasts and Valuations - The report provides earnings per share (EPS) forecasts for key companies, with Muyuan Foods projected at 2.54 yuan for 2025 and 4.81 yuan for 2026, maintaining an "Overweight" rating [36]. - Other companies such as Wens Foodstuffs and Petty Holdings also receive "Overweight" ratings, indicating strong growth potential [36].

（文章来源：证券日报） 证券日报网讯 2月11日，科前生物在互动平台回答投资者提问时表示，公司是一家专注于兽用生物制品 研发、生产、销售及动物防疫技术服务的生物医药企业，主要产品是非国家强制免疫猪用疫苗和禽用疫 苗。 ...

证券日报网讯 2月11日，科前生物在互动平台回答投资者提问时表示，公司紧紧围绕国家饲用蛋白减量 替代重大战略，与农业微生物资源发掘与利用全国重点实验室开展紧密合作，在利用黑水虻与微生物联 合转化畜禽粪便及餐余垃圾生产昆虫蛋白领域，进行了规模化养殖工艺、自动化养殖设备的研制探索， 初步形成了一套黑水虻规模化转化农业有机废弃物的系统解决方案，为后期完善与推广应用奠定了基 础。 （文章来源：证券日报） ...

证券日报网讯 2月11日，科前生物在互动平台回答投资者提问时表示，上市公司股价受宏观经济形势、 政策变化、市场情绪等多重因素综合影响。公司将坚定秉持高质量发展理念，持续加大研发投入，不断 提升经营发展能力，努力回馈投资者。 （文章来源：证券日报） ...

公司新兽药注册证书于2026年2月9日获批，产品为猪圆环病毒2型重组杆状病毒灭活疫苗(CH17株，悬 浮培养)，用于预防猪圆环病毒2型感染引起的疾病。 以上内容基于公开资料整理，不构成投资建议。 经济观察网科前生物(688526)近期获得农业农村部批准的新兽药注册证书，产品为猪圆环病毒2型重组 杆状病毒灭活疫苗(CH17株，悬浮培养)，用于预防猪圆环病毒2型感染引起的疾病。该产品的获批将丰 富公司产品线，但上市销售前还需取得产品批准文号，市场推广和销售情况存在不确定性。 产品研发进展 ...

Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]